The First Case of Firehawk<sup>®</sup> in Kazakhstan Completed

Astana, Kazakhstan – The first case of Firehawk® Rapamycin Target Eluting Coronary Stent System ("Firehawk®") in Kazakhstan was successfully completed in National Scientific Medical Center in Astana, Kazakhstan. Firehawk® is a drug-eluting stent in-house developed by Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®").
 
The surgery was performed by Professor Stambol Beglan of Interventional Cardiology and Endovascular X-ray Surgery Department of National Scientific Medical Center in Astana, Kazakhstan. The patient is an 80-year-old female with calcified CTO at mid-LAD. Professor Stambol Beglan implanted two Firehawk® stents (3.0x38mm, 3.5x38mm) in the LAD lesion, and the two stents were precisely implanted to the LAD and successfully crossed the lesion with full dilation and good apposition. Professor Stambol Beglan was satisfied with the surgical outcome and spoke highly of Firehawk®’s excellent crossability and pushability.
 
In 2013, the concept of a "Silk Road Economic Belt" was put forward by President Xi Jinping during his visit to Kazakhstan, which together with the "21st Century Maritime Silk Road" forms the "Belt and Road" initiative. The "Belt and Road" initiative integrates not only trade and investment but healthcare and medical treatment as well in Eurasia. In recent years, under the guidance of the "Belt and Road" initiative, MicroPort® is expanding its international business in countries involved in the initiative. Currently, the products of MicroPort® have entered more than 10 "Belt and Road" countries such as India, Pakistan, Indonesia, the Philippines, Thailand, Kazakhstan, Malaysia, Poland, Romania, South Korea, and Turkey.
 
Dr. Linda Lin, First Vice President of MicroPort® International Business, said: "The outcome of the first Firehawk® case in Kazakhstan won high recognition from local physicians and patients, which paves the way for MicroPort® to further promote its products in Kazakhstan and even the whole Middle Asia. We will continue to introduce more high-quality medical devices to Kazakhstan and other countries involved in the "Belt and Road" initiative, to offer better service to patients."